In addition, the results of our TMA analyses of a cohort of CRC patients strengthened our in silico data, as we found that high levels of HDAC2 expression were related to tumor tissues mainly localized in the proximal colon and with greater vascular invasion. This evidence concerns the gene HDAC2 and colorectal carcinoma.